Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Brenner, B; Grabowski, EF; Hellgren, M; Kenet, G; Massicotte, P; Manco-Johnson, M; Mathew, P; Muntean, W; Schlegel, N; Nowak-Göttl, U.
Thrombophilia and pregnancy complications.
THROMB HAEMOST. 2004; 92(4): 678-681. Doi: 10.1267/THRO04040678 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Muntean Eugen
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
The implications of currently available data on the association of gestational vascular complications with thrombophilia are presented in this consensus report. Screening is recommended for women with the following previous complications: fetal loss including three or more first trimester loss, two or more second trimester loss, or any stillbirth; early, severe or recurrent preeclampsia and severe intrauterine growth restriction. Maternal antithrombotic therapy is currently evaluated in women with thrombophilia and previous complications.
Find related publications in this database (using NLM MeSH Indexing)
Abortion, Habitual - blood
Adult - blood
Female - blood
Fibrinolytic Agents - contraindications
Humans - contraindications
Practice Guidelines - contraindications
Pregnancy - contraindications
Pregnancy Complications, Hematologic - drug therapy
Pregnancy Outcome - drug therapy
Thrombophilia - complications

Find related publications in this database (Keywords)
thrombophilia
pregnancy
antithrombotic therapy
fetal loss
© Med Uni Graz Impressum